A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs) have taken in large ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
U.S. automaker General Motors will be banned for five years from disclosing consumers' sensitive geolocation and driver ...
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
The new report says pharmacy benefit managers marked up prices of various drugs to earn billions in profits.
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...